Laptop with hands

Academic approach

MS sherpa

MS sherpa is part of several study programs, collaborating with several clinics and academic partners.

Study overview

DOT MS Study

Goal

Can we safely discontinue first-line medication in MS patients with long-term absence of inflammation, without the return of inflammatory disease activity clinically and radiologically?

Is it possible to detect and predict (return of) inflammatory disease activity and disease progression with digital biomarkers using mobile applications such as MS sherpa?

Study group

(Amsterdam UMC) N= 130 patients.

Planning

Protocol approved by METC, started: Jun20
recruitment ongoing.

APPS MS study

Goal

Develop and explore measuring methods using built-in sensors of conventional smartphones and wearables to quantify fatigue, disease activity and progression in a day-to-day setting in patients with MS.

Study group

N= 125, 100 persons with MS, 25 healthy controls, collaboration with Amsterdam UMC, last patient visited in February 2021.

Planning

In data analysis phase, scientific publications are in preparation.

MS Self study

Goal

The aim of this study is to assess the validity, sensitivity and ease of use of new mobile self-monitoring tools for people with Relapsing-Remitting Multiple Sclerosis.

Study group

N= 25 MS patients, N= 79 healthy controls.

Planning

Completed.

MSSM (MS)

Goal

In this study, the primary aim is to evaluate the effectiveness, in terms of self-efficacy control and quality of life, and the cost-effectiveness of self-monitoring based management of MS through the use of the MS sherpa app compared to care as usual without MS sherpa.

Study group

N= 225, 125 intervention group, 100 control group, collaboration with Amsterdam UMC, 3 STZ hospitals, MS4Research institute and the Radboud University.

Planning

Planned submission to METC: August 31, 2021.

This study is funded by Nationaal MS Fonds and NWO.